Akero Therapeutics, Inc. (FRA:0K4)
Germany · Delayed Price · Currency is EUR 46.70
+0.04 (0.09%)
At close: Nov 28, 2025
Akero Therapeutics Market Cap
Akero Therapeutics has a market cap or net worth of €3.85 billion as of December 1, 2025. Its market cap has increased by 88.59% in one year.
Market Cap
3.85B
Enterprise Value
3.01B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€46.70
Market Cap Chart
Since June 20, 2019, Akero Therapeutics's market cap has increased from 439.48M to 3.85B, an increase of 777.14%. That is a compound annual growth rate of 39.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 3.85B | 105.53% |
| Dec 31, 2024 | 1.88B | 59.37% |
| Dec 29, 2023 | 1.18B | -50.92% |
| Dec 30, 2022 | 2.40B | 269.57% |
| Dec 31, 2021 | 648.82M | -11.40% |
| Dec 31, 2020 | 732.34M | 29.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |